As IL-1β and LCN2 appear to promote breast tumour malignancy and lead to a poorer prognosis, we speculate that β-hydroxybutyrate induced upregulation of their expression might contribute to the observed increased tumorigenesis. This evidence concerns the gene LCN2 and breast neoplasm.